trabectedin,nivolumab,ipilimumab
otsuka,valeo pharmaceutical,pharmamar,bms
['nivo', 'nivolumab', 'ipilimumab', 'sarcoma', 'trabectedin']
#esmo22 #sarcoma early introduction (1st line) of #immunotherapy in met #leiomyosarcoma ipilimumab+nivolumab+trabectedin
1.better orr? - 31.6%
2.2 cr 4 pr 11 sd 2 pd
3.better mpfs? - 7.4mo we need randomized trial, but the 2 cr and the long tail in pfs are encouraging! 
24/7 optimism & enthusiasm in #sarcoma #GIST research and patient care at @VHIO | #SanidadPública | #SinCienciaNoHayFuturo | @MyEsmo Faculty. 
Tweets are my own